
1843 Capital is an early-stage venture capital firm founded in 2016 by Tracy Killoren Chadwell, focused on AgeTech, Longevity, FinTech, and Cybersecurity. The firm invests in technology and tech-enabled companies, with a preference for diverse founding teams.
39% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Their most common stage is series-a (56% of deals). Average disclosed round size is $29.1M (across 16 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $5.4M | Oct 2025 | |
| RRIPPL Care | Series A | $23M | Oct 2024 |
| Series A | — | Oct 2024 | |
| Series B | — | Apr 2024 | |
| Series B | $60M | Jan 2024 | |
| RRIPPL Care | Series A | $55M | Jan 2024 |
| Series A | $55M | Jan 2024 | |
| Series B | $25M | Apr 2022 | |
| Series A | $12M | Apr 2022 | |
| Series C | $83M | Jan 2022 | |
| AAvanti Financial Group | Series A | $37M | Mar 2021 |
| Series B | $15M | Jan 2021 | |
| Series A | $10M | Feb 2020 | |
| Series A | $14M | Oct 2018 | |
| SSilvernest | Seed | $1.3M | Jun 2017 |
| Series A | $15M | — | |
| AAvanti | Series A | $37M | — |
| Unknown | $18M | — |
Top Co-Investors
ARCH Venture Partners5 shared
Kin Ventures4 shared
Mass General Brigham Ventures4 shared
F-Prime Capital4 shared
JSL Health Capital4 shared
General Catalyst4 shared
Operator Collective2 shared
GV2 shared
Icon Ventures2 shared
GingerBread Capital2 shared
SemperVirens Venture Capital2 shared
Muse Capital2 shared
Actions Capital2 shared
Able Partners2 shared
Emerson Collective2 shared
Avestria Ventures2 shared
Felicis2 shared
Mastercard2 shared
In-Q-Tel2 shared
Capital One Ventures2 shared
Last updated: 7 October 2026